Histopathology

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

Celebrating IBMS exam success

It is time to celebrate the success of more IBMS members in the Diploma of Expert Practice (DEP) or Advanced Specialist Diploma (ASD) in Histological Dissection and the DEP in Immunocytochemistry exams.

Advanced and consultant practice roles

Sarah May and Chris Ward from the IBMS look at advanced and consultant roles and discuss new developments and qualifications.

Tissue contamination distracts AI

In a new study, scientists trained three AI models to scan microscope slides of placenta tissue to detect blood vessel damage, estimate gestational age and classify macroscopic lesions.

Digital pathology cleared for use

New research has led to the UK government approving the use of digital pathology to help speed up analysis of cancer screening samples.

Two decades of hHER2 testing

This year marks the 20th anniversary of Her2 breast cancer testing at the Royal Cornwall Hospital. Senior Biomedical Scientist Mary Jones looks back over the past two decades.

Precision pathology for cancer with new ai tool

A new AI tool interprets medical images with unprecedented clarity, according to the results of a new study.

Tech news: January 2024

This month's top tech news stories

My lab: digital pathology service

Rachael Nicholson gives a guided tour of the Medica MedPath Digital Pathology Hub in Runcorn.

AI grading the severity of a rare cancer

Professor Christina Messiou talks us through her study that shows AI is nearly twice as good at grading the aggressiveness of a rare form of cancer from scans as the current method.

Top